News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
234 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17909)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Biotech Beach
CogenDx Release: New Study Explores Frequency of Butyrylcholinesterase (BChE) Deficiency in the United States
In the study of 13,301 patients, 8 percent were predicted to have moderate BChE deficiency while 0.06 percent were predicted to have severe BChE deficiency.
November 2, 2017
·
2 min read
Business
CytoSorbents to Report Q3 2017 Operating and Financial Results
CytoSorbents’ management will host a live conference call and presentation webcast that will recount both operational and financial progress during Q3 2017 followed by a question and answer session.
November 2, 2017
·
4 min read
Flexpoint Sensor Systems and Medical Technology Partner Neofect Remain on Remarkable Growth Path Together
Flexpoint Sensor Systems today announced receipt of multiple and recurring purchase orders from award winning medical rehabilitation technology provider, Neofect.
November 2, 2017
·
3 min read
Business
Biocept to Release Third Quarter Financial Results and Host Investor Conference Call on November 9, 2017
The Company will host a conference call for the investment community to discuss the results and answer questions at 4:30 p.m. Eastern time.
November 2, 2017
·
1 min read
Business
Catabasis Pharmaceuticals to Report Third Quarter 2017 Financial Results and Recent Corporate Developments on Thursday, November 9
Jill C. Milne, Ph.D., Chief Executive Officer, will host a conference call and webcast at 4:30pm ET to provide an update on corporate developments and to discuss third quarter financial results.
November 2, 2017
·
1 min read
Business
Aevi Genomic Medicine Reports Third Quarter 2017 Financial Results
Aevi Genomic Medicine announced today financial and operational results for the quarter ended September 30, 2017 and provided a corporate update.
November 2, 2017
·
11 min read
Business
Nemaura Medical Reports Second Quarter 2017 Financial Results
G&A expenditure up by 134% over same quarter in 2016.
November 2, 2017
·
3 min read
Business
Syngenta Obtains Non-Exclusive IP License From Broad Institute for CRISPR-Cas9 Genome-Editing Technology for Agriculture Applications
CRISPR-Cas9 genome editing technology complements Syngenta’s already robust plant breeding innovation toolbox
November 2, 2017
·
2 min read
Policy
FDA Grants Orphan Drug Designation for Retrotope’s RT001 in the Treatment of Phospholipase 2G6 (PLA2G6)-Associated Neurodegeneration
Physicians collaborating with Retrotope previously received approval from the FDA to test RT001 in Expanded Access trials of two patients having Infantile Neuroaxonal Dystrophy.
November 2, 2017
·
3 min read
Biotech Bay
New Study Reports Favorable Results for Intuitive Surgical’s Flexible Robotics Platform
The findings suggest that using the platform is a safe and feasible approach to sample lung tissue.
November 2, 2017
·
4 min read
Previous
21 of 24
Next